Bitter roots : the search for healing plants in Africa / Abena Dove Osseo-Asare.

By:

Osseo-Asare, Abena Dove Agyepoma [author.]

Material type: Text

text

Media type:

computer

Carrier type:

online resource

ISBN:

9780226086163
022608616X
9781306180665
130618066X

Subject(s): Genre/Form:

Additional physical formats: Print version:: Bitter roots.DDC classification:

615.3/21 23

LOC classification:

RS181 .O87 2014eb

NLM classification:

QV 770 HA1

Online resources:

Click here to access online

Contents:

Introduction: From plants to pharmaceuticals -- Take Madagascar periwinkle for leukemia and pennywort for leprosy -- Take grains of paradise for love -- Take arrow poisons for the heart -- Take bitter roots for malaria -- Take Kalahari hoodia for hunger -- Conclusion: Toward bioprosperity.

Summary: "For over a century, plant specialists worldwide have sought to transform healing plants in African countries into pharmaceuticals. And for equally as long, conflicts over these medicinal plants have endured, from stolen recipes and toxic tonics to unfulfilled promises of laboratory equipment and usurped personal patents. In this book the author draws on publicly available records and extensive interviews with scientists and healers in Ghana, Madagascar, and South Africa to interpret how African scientists and healers, rural communities, and drug companies, including Pfizer, Bristol-Myers Squibb, and Unilever have sought since the 1880s to develop drugs from Africa's medicinal plants. Osseo-Asare recalls the efforts to transform six plants into pharmaceuticals: rosy periwinkle, Asiatic pennywort, grains of paradise, Strophanthus, Cryptolepis, and Hoodia. Through the stories of each plant, she shows that herbal medicine and pharmaceutical chemistry have simultaneous and overlapping histories that cross geographic boundaries. At the same time, Osseo-Asare sheds new light on how various interests have tried to manage the rights to these healing plants and probes the challenges associated with assigning ownership to plants and their biochemical components. A fascinating examination of the history of medicine in colonial and postcolonial Africa, Bitter Roots will be indispensable for scholars of Africa; historians interested in medicine, biochemistry, and society; and policy makers concerned with drug access and patent rights"--Provided by publisher.

Item type:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Home library	Collection	Call number	Materials specified	Status	Date due	Barcode
Electronic-Books	OPJGU Sonepat- Campus	E-Books EBSCO			Available

"For over a century, plant specialists worldwide have sought to transform healing plants in African countries into pharmaceuticals. And for equally as long, conflicts over these medicinal plants have endured, from stolen recipes and toxic tonics to unfulfilled promises of laboratory equipment and usurped personal patents. In this book the author draws on publicly available records and extensive interviews with scientists and healers in Ghana, Madagascar, and South Africa to interpret how African scientists and healers, rural communities, and drug companies, including Pfizer, Bristol-Myers Squibb, and Unilever have sought since the 1880s to develop drugs from Africa's medicinal plants. Osseo-Asare recalls the efforts to transform six plants into pharmaceuticals: rosy periwinkle, Asiatic pennywort, grains of paradise, Strophanthus, Cryptolepis, and Hoodia. Through the stories of each plant, she shows that herbal medicine and pharmaceutical chemistry have simultaneous and overlapping histories that cross geographic boundaries. At the same time, Osseo-Asare sheds new light on how various interests have tried to manage the rights to these healing plants and probes the challenges associated with assigning ownership to plants and their biochemical components. A fascinating examination of the history of medicine in colonial and postcolonial Africa, Bitter Roots will be indispensable for scholars of Africa; historians interested in medicine, biochemistry, and society; and policy makers concerned with drug access and patent rights"--Provided by publisher.